Correction to: European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for trainees
Eur J Nucl Med Mol Imaging. 2023 Jan;50(2):630.
doi: 10.1007/s00259-022-06037-8.
1 Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands.
2 Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany.
3 Division of Nuclear Medicine and Oncological Imaging, University Hospital of Liège, Belgium and GIGA‑CRC In Vivo Imaging, University of Liège, Liège, Belgium.
4 Department of Nuclear Medicine, University Würzburg, Würzburg, Germany.
5 Division of Nuclear Medicine, Department of Biomedical Imaging and Image‑Guided Therapy, Medical University of Vienna, Vienna, Austria.
6 Center for Biomarker Research in Medicine (CBmed GmbH), Graz, Austria.
7 Nuclear Medicine Department, Medical University of Warsaw, ul. Banacha 1 a, 02‑097, Warsaw, Poland. [email protected].